Ketamine-dependent patients who exhibited psychosis demonstrated levels of spatial problem solving and verbal memory impairment similar to those of patients with schizophrenia.
Despite the recognition that early daily tobacco use likely increases the risk for later psychosis, investigation of the effect of covariates such as substance use, existing psychotic features, or parental/family factors was lacking in the literature.
Investigators determined infections in the first year of life to be the "sensitive period" for risk of adult nonaffective psychosis.
Children who are involved in sibling bullying are at a higher risk of developing a psychotic disorder.
Most people receiving a first diagnosis of a psychotic disorder have had some indication of mental health need in the previous year.
Use of virtual reality environments in which participants interact with computer-controlled situations or avatars enables a more fine-tuned approach to exposure in the context of cognitive behavioral therapy.
A combination of an SSRI and antipsychotics in a clinical setting most likely does not lead to a further deterioration of metabolic variables to a clinically significant degree.
A meta-analysis of randomized, controlled trials compared the use of benzodiazepines alone or in combination with antipsychotic or antihistamine medications in patients experiencing acute psychotic illness.
Multiple treatment failure in children with first-episode psychosis was more common among patients with comorbid autism spectrum disorders.
The treated incidence of psychotic disorders was shown to range from 6.0 to 46.1 per 100,000 person-years across various regions.
The use of atypical antipsychotics can be reduced with the implementation of a peer review prior authorization policy.
Patient behavior is affected with factors associated with readmission in THA patients.
These findings suggest that there are critical periods of development associated with a higher risk of persistent negative symptoms.
Child maltreatment is significantly more prevalent in young individuals who present with UHR symptoms compared with controls.
Benefits of NMDA receptor agonists in patients with schizophrenia include improvements with memory and reading.
Studying cognition deficits during the clinical high risk period allows researchers to observe cognitive defects before chronicity and long-term medication use obscure the core deficits.
Approximately 2.5% of people worldwide are estimated to have bipolar spectrum disorders, which are a significant cause of neuropsychiatric disability.
Study provides further evidence for the effects of white matter fiber abnormalities and neuroinflammation on positive symptoms in patients with schizophrenia.
New findings provide an insight about the association between white matter microstructure and the severity of schizophrenia clinical symptoms.
Researchers used voxel-based morphometry, which allows examination on a voxel-wise basis across the whole brain, to assess whether structural abnormalities in schizophrenia are static or progressive.
TSPO expression is frequently used as a biomarker for brain inflammation during PET imaging.
Researchers explored the role of the dysregulated cannabinoid receptor system in patients diagnosed with schizophrenia.
Whereas the expression levels of CDK4 and MCM7 were significantly decreased only in the acute state, POLD4 was significantly decreased in the acute and remission states in the patients diagnosed with schizophrenia.
Commonly used medications have been linked to an increased risk of hospitalization for dehydration and heat-related illness.
A diagnosis of schizophrenia and a length of stay of 90 days or more are the strongest predictors of polypharmacy.
At 12 months, researchers found a significant association between smoking reduction and suicidality.
Genetic risk for psychosis influences reward processing in healthy adolescents.
Exposure to Stressful Triggers Increases Risk for Violent Criminality Irrespective of Psychiatric ConditionJuly 13, 2016
The largest 7-day absolute risk of criminal violence was observed after exposure to violence in patients diagnosed with schizophrenia, bipolar disorder, as well as in unaffected individuals.
The FDA has mandated new warnings to include a list of compulsive behaviors.
University of Washington Tobacco Scholar Joseph Cerimele, MD, MPH, discusses the relationship between smoking and psychiatric illness.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- Abnormalities of Cortical Thickness in Bipolar Disorder With Auditory Hallucinations
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed
- Examining Associations Between Diabetes and Effects on Cognition
- Untreated Depression Common in Women of Childbearing Age
- Incidence of Psychiatric Disorders in Rheumatoid Arthritis
- Effect of Antidepressant Class, Dose on Pediatric Anxiety Disorders